Categories Multiple Myeloma

Multiple Myeloma Treatment Market Innovative Strategy by 2028 | Johnson & Johnson, Roche …

Multiple Myeloma Treatment Market Innovative Strategy by 2028 | Johnson & Johnson, Roche … North America, Europe, China, Japan, Rest of the World, September 2020,– – The Multiple Myeloma Treatment Market research report includes an in-sight study of the key Global Multiple Myeloma Treatment Market prominent players along with the company profiles and planning adopted by them. This helps the […]

Read More
Categories Multiple Myeloma

Stem Cell Transplantation as a Treatment for Multiple Myeloma – Mayo Clinic

Stem Cell Transplantation as a Treatment for Multiple Myeloma – Mayo Clinic Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones. In this video, Mayo Clinic hematologist Dr. David Dingli explains the role stem cell transplants play in treating […]

Read More
Categories Cancer

Global LAMEA Oncology/Anti-cancer drugs Market Trends, Growth Demand, Opportunities …

Global LAMEA Oncology/Anti-cancer drugs Market Trends, Growth Demand, Opportunities …  The LAMEA Oncology/Anti-cancer drugs market report, published by Syndicate Market Research, offers an organized assessment of the important aspects of the global LAMEA Oncology/Anti-cancer drugs market, serving as a means to the better evaluation of the present and future situations of the market. The report provides a […]

Read More
Categories Cancer

Seven-year-old girl with cancer goes to school from her hospital bed using a robot

Seven-year-old girl with cancer goes to school from her hospital bed using a robot Seren Mawson, seven, cannot physically attend school as she is receiving treatment for acute lymphoblastic leukaemia (Picture: Caters News) A robot is helping a seven-year-old girl with cancer continue to attend school from her hospital bed. Seren Mawson has spent months […]

Read More
Categories Multiple Myeloma

Selinexor, Bortezomib, Dexamethasone Combination Effective for Patients with Multiple Myeloma

Selinexor, Bortezomib, Dexamethasone Combination Effective for Patients with Multiple Myeloma Results from the phase 3 BOSTON study, published in The Lancet, suggested that a once-per-week combination regimen of selinexor (Xpovio), bortezomib (Velcade), and dexamethasone (Ozurdex) is a novel, effective, and convenient treatment option for patients with multiple myeloma who have received 1 to 3 previous […]

Read More